Sun Pharmaceuticals Industries Ltd. aims to go from the current 7% R&D revenue level to 9% in terms of overall R&D spend, Managing Director Dilip Shanghvi said. "This will help bring newer and innovative products." Currently, the company spends around 40% of its overall R&D budget on innovative products.